Maurizio Iacobone
Overview
Explore the profile of Maurizio Iacobone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1544
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Araujo-Castro M, Herrera A, Wang Y, Wang Z, Sledzinski M, Hellmann A, et al.
J Clin Endocrinol Metab
. 2025 Mar;
PMID: 40048695
Introduction: Postoperative outcomes of patients with normotensive pheochromocytomas are poorly documented. We aimed to evaluate the impact of preoperative hypertension on post-operative outcomes following adrenalectomy for pheochromocytoma. Methods: An international...
2.
Verhoeff K, Parente A, Wang Y, Wang N, Wang Z, Sledzinski M, et al.
Ann Surg Oncol
. 2025 Jan;
32(4):2376-2378.
PMID: 39865203
No abstract available.
3.
Verhoeff K, Parente A, Wang Y, Wang N, Wang Z, Sledzinski M, et al.
Ann Surg Oncol
. 2024 Dec;
32(3):1709-1720.
PMID: 39633172
Objective: The impact of obesity on outcomes after adrenalectomy for pheochromocytoma is unclear. This study aims to evaluate outcomes after minimally invasive and open adrenalectomy for pheochromocytoma in patients with...
4.
Crimi F, Turatto F, DAlessandro C, Sussan G, Iacobone M, Torresan F, et al.
J Endocrinol Invest
. 2024 Oct;
48(3):711-720.
PMID: 39382628
Background: The adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy originating from the adrenal cortex. These patients usually undergo chemotherapy with etoposide, doxorubicin, cisplatin and mitotane (EDP-M) in...
5.
Marini F, Marcucci G, Giusti F, Arvat E, Benvenga S, Bondanelli M, et al.
Eur J Endocrinol
. 2024 Oct;
191(4):416-425.
PMID: 39365596
Objective: Atypical parathyroid tumor (aPT) and parathyroid carcinoma (PC) are extremely rare parathyroid neoplasms, accounting together for <2% of all parathyroid tumors. They often present an overlapping clinical phenotype, sharing...
6.
Torresan F, Rossi F, Caputo I, Zanin S, Caroccia B, Mattarei A, et al.
Hypertension
. 2024 Oct;
81(12):2468-2478.
PMID: 39355924
Background: Primary aldosteronism (PA), the most common curable salt-dependent form of arterial hypertension, features renal K loss and enhanced Na reabsorption. We investigated whether the electrolyte, water, and TonEBP (tonicity-responsive...
7.
Parente A, Verhoeff K, Wang Y, Wang N, Wang Z, Sledzinski M, et al.
Eur Urol Focus
. 2024 Sep;
PMID: 39278764
Background And Objective: Robotic adrenalectomy (RA) has attracted interest as an alternative to laparoscopic adrenalectomy (LA) for patients with pheochromocytoma, although its beneficial effects are uncertain. Our aim was to...
8.
Dughiero S, Torresan F, Censi S, Mian C, Carrillo Lizarazo J, Iacobone M
Cancers (Basel)
. 2024 Aug;
16(16).
PMID: 39199638
Background: Postoperative hypoparathyroidism (HypoPTH) is the most common complication following total thyroidectomy. Several risk factors have been identified, but data on postoperative follow-up are scarce. Methods: The study focused on...
9.
Schiavone D, Crimi F, Cabrelle G, Pennelli G, Sacchi D, Mian C, et al.
Br J Surg
. 2024 Aug;
111(8).
PMID: 39129619
Background: Lugol solution is often administered to patients with Graves' disease before surgery. The aim is to reduce thyroid vascularization and surgical morbidity, but its real effectiveness remains controversial. The...
10.
Torresan F, Iacobone C, Giorgino F, Iacobone M
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000254
Pheochromocytomas and paragangliomas (PPGLs) are rare neoplasms producing catecholamines that occur as hereditary syndromes in 25-40% of cases. To date, PPGLs are no longer classified as benign and malignant tumors...